Amryt Pharma Share Discussion Threads

[gnnmartin] 23/6/2022 20:41

Thanks. A pity.

[onceaday] 23/6/2022 15:08

The CVR was awarded upon CHMP opinion not EC approval. But..it's only $5M in total.

[gnnmartin] 23/6/2022 14:58

European Commission Approves Filsuvez® for the treatment of Dystrophic and Junctional EB. Does this mean a payment on the contingent rights? Or is it too late for that?

[chica1] 22/6/2022 16:19

Where's AP103? https://finance.yahoo.com/news/krystal-biotech-submits-biologics-license-110000212.html

[richpassi] 05/6/2022 19:15

Good not could !

[richpassi] 05/6/2022 19:14

How could I say anything else ! Hope you could Pap ;)

[papillon] 05/6/2022 13:06

👍 richpassi 🤣🤣🤣🤣

[richpassi] 05/6/2022 10:41

I wouldn't ;) lol

[onceaday] 04/6/2022 15:29

Does Mrs Claris Bemedicta advise buying Amryt? 😄😄😄

[exfm] 04/6/2022 12:07

Just catching up on this; so this was from the announcement:The total amount payable to CVR Holders will be approximately USD$5.7million. Each CVR Holder will be issued with one loan note of USD$0.0995 for each CVR they hold (each a "Loan Note"). The certificates for the Loan Notes will be held by the Company's Registrar, Link Group ("Link"), in electronic form on behalf of each CVR Holder. So I assume this means that we will receive 9.95 USD cents for each CVR. This will actually arrive on the 14th September. Is this other peoples understanding? https://otp.tools.investis.com/clients/uk/amryt_pharmaceuticals_dac1/usn/usnews-story.aspx?cid=1375&newsid=83319

[onceaday] 19/5/2022 18:59

Oh great. That's worthless.in that case.

[40plus] 19/5/2022 17:38

Revenue CVR is also timebound:- "A contingent entitlement of up to a maximum amount of $35,000,000 on Amryt achieving a 12-Month Trailing Net Product Revenue in excess of $75,000,000 from sales of AP101 prior to 30 June 2024"

[onceaday] 18/5/2022 16:53

There are three CVRs. EMA, FDA and $75M revenue.The first two are time-bound but I think revenue is not. Happy to be corrected.

[chica1] 18/5/2022 10:42

Well at least the $ is strong (and should be) when the time comes. I'm surprised we're getting anything,I thought the CVR's were for FDA approval not EMA. I can't see the FDA changing their decision because I think there's been a fudge at the EMA as Episalvan already had Partial Thickness Wounds approval (which the FDA already rejected in 2016)

[onceaday] 17/5/2022 16:39

Ler's hope your broker will accept a dollar denominated cheque! :-)

[punter6] 17/5/2022 15:20

Great,we'll be able to buy a few rounds to celebrate so on 22nd September!!

[40plus] 08/5/2022 11:12

Near end of Q1 2022 Conf Call on 4th May, Rory Nealon advises EMA CVR to payout at approx 9.9 US Cents per CVR payable in around 4 Months time.

[onceaday] 04/5/2022 13:05

An even bigger loss than the same quarter last year. Cash pile shrinking... Will Amryt ever be profitable?

[bazworth] 26/4/2022 13:48

Onwards & upwards!

[punter6] 26/4/2022 12:40

Are we expecting good things from the Q4 results next Wednesday?!

[onceaday] 22/4/2022 16:49

If you are interested in the format of the post-CRL meeting then here are the guidance notes.. https://www.fda.gov › mediaPDF Post-Complete Response Letter Meetings Between FDA and ANDA Applicants ...